Ken Griffin Intercure Ltd. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Intercure Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 5,600 shares of INCR stock, worth $10,472. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,600
Previous 800
600.0%
Holding current value
$10,472
Previous $2,000
450.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding INCR
# of Institutions
26Shares Held
3.98MCall Options Held
53.1KPut Options Held
200-
Ibex Investors LLC1.89MShares$3.53 Million7.67% of portfolio
-
ETF Managers Group, LLC Summit, NJ811KShares$1.52 Million0.06% of portfolio
-
Toroso Investments, LLC Massapequa, NY460KShares$859,7730.01% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6213KShares$397,3750.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD107KShares$200,8640.04% of portfolio
About Intercure Ltd.
- Ticker INCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,133,900
- Market Cap $84.4M
- Description
- InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...